Respiratory Syncytial Virus

Disease State Hub

Featured

Respiratory Diseases Roundup
Respiratory Diseases Roundup
04/06/2026
Kate Young
New reports link SARS-CoV-2 and RSV to persistent cardiopulmonary risk and describe distinct postviral lung and brain changes in a mouse model.
04/06/2026
Respiratory Diseases Roundup
Respiratory Diseases Roundup
04/03/2026
Kate Young
This roundup explores updated 2024-2025 COVID-19 vaccine effectiveness data, an FDA-cleared 4-pathogen home test, and new evidence on metformin for long COVID risk.
04/03/2026
Research Summary
Research Summary
02/09/2026
Ashton L. Stahl
A large pragmatic randomized trial evaluated whether a bivalent respiratory syncytial virus (RSV) prefusion F protein-based vaccine could reduce RSV-related hospitalizations among adults aged 60 years or...
02/09/2026

Interactive Features

3-in-30
3-in-30
10/29/2015
Anthony Calabro, MA
Test your knowledge of the latest Advisory Committee on Immunization Practices guidance, vaccine coadministration with influenza and respiratory syncytial virus shots, and state-level access changes. Three...
10/29/2015

Clinical Insights

Multidisciplinary Roundtable
Multidisciplinary Roundtable
08/27/2025
William Schaffner, MD; Tina Tan, MD, FIDSA, FPIDS, FAAP; Jennifer Walsh DNP, CPNP-PC, CNE
William Schaffner, MD; Tina Q. Tan, MD, FIDSA, FPIDS, FAAP; and Jennifer Walsh, DNP, CPNP, CNE, discuss the latest ACIP vaccine guideline updates for 2025–2026, including recommendations on influenza, RSV,...
08/27/2025
Conference Coverage
Conference Coverage
10/13/2024
Ashish Bhargava, MD
In this video, Ashish Bhargava, MD, discusses the results of his team's study on the risk factors associated with a longer hospital stay in adult patients with respiratory syncytial virus (RSV. He talks...
10/13/2024
Conference Coverage
Conference Coverage
05/02/2024
William Schaffner, MD
In this video, William Schaffner, MD, provides an overview of the topics presented at the 2023 Annual Conference on Vaccinology Research, hosted by the National Foundation for Infectious Diseases, including...
05/02/2024
Expert Q&A
Expert Q&A
03/18/2024
The FDA approved the use of Pfizer’s bivalent prefusion f vaccine in older adults to protect against respiratory syncytial virus. A Pfizer spokesperson answered questions about the study that helped lead to...
03/18/2024
Expert Q&A
Expert Q&A
03/18/2024
Are there benefits to vaccinating women who are pregnant with a vaccine that prevents respiratory syncytial virus (RSV)-related illness in newborns? A new study examined this topic.
03/18/2024